2023
DOI: 10.1002/jmv.29085
|View full text |Cite
|
Sign up to set email alerts
|

Clinical effectiveness of oral antiviral agents in older patients with COVID‐19 based on real‐world data

Ya‐Wen Tsai,
Jheng‐Yan Wu,
Ting‐Hui Liu
et al.

Abstract: To the Editor, Chen et al. 1 raised several concerns about our recent study. 2 First, some confounding factors, especially for the comorbidities, were not controlled.Based on their instructive suggestions, we updated our analysis using propensity score matching to balance the demographic features, including cardiac arrhythmias, chronic kidney disease, cerebral infarction, heart failure, hyperlipidemia, sleep apnea, and transplantation between the study and groups.Chen et al. 1 have drawn attention to the impor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…Afterall, we divided the included patients into two cohorts: those receiving molnupiravir (the treated group) and those not receiving molnupiravir (the untreated group). The demographic characteristics (i.e., age, sex, race, and socioeconomic status), comorbidities (hypertensive diseases, neoplasms, chronic lower respiratory diseases, overweight/obesity, type 2 diabetes mellitus, chronic kidney diseases, chronic liver disease, cardiovascular diseases and nicotine dependence) of the included patients were collected as previous studies ( Hsu et al, 2023a ; Tsai et al, 2023 ; Wu et al, 2023 ).…”
Section: Methodsmentioning
confidence: 99%
“…Afterall, we divided the included patients into two cohorts: those receiving molnupiravir (the treated group) and those not receiving molnupiravir (the untreated group). The demographic characteristics (i.e., age, sex, race, and socioeconomic status), comorbidities (hypertensive diseases, neoplasms, chronic lower respiratory diseases, overweight/obesity, type 2 diabetes mellitus, chronic kidney diseases, chronic liver disease, cardiovascular diseases and nicotine dependence) of the included patients were collected as previous studies ( Hsu et al, 2023a ; Tsai et al, 2023 ; Wu et al, 2023 ).…”
Section: Methodsmentioning
confidence: 99%